RxDoctor Payments Data

Garry Summer, MD

Family Medicine · Mayodan, NCNPI 1346219722

Payments from drug & device makers

$195in general payments, 2019–2025

Across 13 payments — averaging $14.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shire North American Group Inc$37
  • Pfizer$35
  • Novo Nordisk$25
  • Lilly USA, LLC$23
  • Amgen$18
  • Hologic Sales And Service, LLC$15
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$195100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$195 in reported general payments places this provider in the 40th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$128,372
Medicare patients
269
Services billed
1,692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide113$128,966
JardianceEmpagliflozin57$65,659
OzempicSemaglutide38$63,391
EliquisApixaban51$55,312
MounjaroTirzepatide18$18,411
JanuviaSitagliptin Phosphate14$14,055
Tresiba Flextouch U-200Insulin Degludec18$13,573
Advair HfaFluticasone Propion/Salmeterol18$5,861
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$4,817
SymbicortBudesonide/Formoterol Fumarate13$4,658
Atorvastatin Calcium483$3,506
Novolog FlexpenInsulin Aspart13$2,718
Amlodipine Besylate459$2,690
Varenicline Tartrate11$2,660
Omeprazole226$2,236

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$23$147,378131 claims
Novo NordiskOzempic$25$63,39138 claims
PfizerEliquis$35$55,31251 claims
MerckJanuvia$13$14,05514 claims
AstraZenecaSymbicort$14$4,65813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Mayodan

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →